Literature DB >> 18086955

Relation of dietary salt and aldosterone to urinary protein excretion in subjects with resistant hypertension.

Eduardo Pimenta1, Krishna K Gaddam, Monique N Pratt-Ubunama, Mari K Nishizaka, Inmaculada Aban, Suzanne Oparil, David A Calhoun.   

Abstract

Experimental data indicate that the cardiorenal effects of aldosterone excess are dependent on concomitant high dietary salt intake. Such an interaction of endogenous aldosterone and dietary salt has not been observed previously in humans. We assessed the hypothesis that excess aldosterone and high dietary sodium intake combine to worsen proteinuria in patients with resistant hypertension. Consecutive subjects with resistant hypertension (n=84) were prospectively evaluated by measurement of 24-hour urinary aldosterone (Ualdo), sodium, and protein (Uprot) excretion. Subjects were analyzed according to aldosterone status (high: Ualdo >or=12 microg/24 hours; or normal: <12 microg/24 hours) and dietary salt intake based on tertiles of urinary sodium. The mean clinic blood pressure for all of the subjects was 161.4+/-22.4/89.8+/-13.5 mm Hg on an average of 4.3 medications. There was no blood pressure difference between study groups. Uprot was significantly higher in the 38 subjects with high Ualdo compared with the 46 subjects with normal Ualdo (143.0+/-83.8 versus 95.9+/-81.7 mg/24 hours; P=0.01). Among subjects with high Ualdo, Uprot increased progressively across urinary sodium groups (P<0.05). In contrast, there was no difference in Uprot across sodium tertiles among subjects with normal Ualdo. A positive correlation between Uprot and urinary sodium (r=0.47; P=0.003) was observed in subjects with high Ualdo but not in subjects with normal Ualdo (r=0.18; P value not significant). These results suggest that aldosterone excess and high dietary salt combine to increase urinary protein excretion.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18086955     DOI: 10.1161/HYPERTENSIONAHA.107.100701

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  27 in total

1.  Cardiac dimensions are largely determined by dietary salt in patients with primary aldosteronism: results of a case-control study.

Authors:  Eduardo Pimenta; Richard D Gordon; Ashraf H Ahmed; Diane Cowley; Rodel Leano; Thomas H Marwick; Michael Stowasser
Journal:  J Clin Endocrinol Metab       Date:  2011-06-01       Impact factor: 5.958

2.  Disparate effects of eplerenone, amlodipine and telmisartan on podocyte injury in aldosterone-infused rats.

Authors:  Wei Liang; Cheng Chen; Jing Shi; Zhilong Ren; Fengqi Hu; Harry van Goor; Pravin C Singhal; Guohua Ding
Journal:  Nephrol Dial Transplant       Date:  2010-08-20       Impact factor: 5.992

Review 3.  Hypertension in African Americans.

Authors:  Nomsa Musemwa; Crystal A Gadegbeku
Journal:  Curr Cardiol Rep       Date:  2017-10-28       Impact factor: 2.931

4.  Histone demethylase LSD1 deficiency and biological sex: impact on blood pressure and aldosterone production.

Authors:  Yuefei Huang; Pei Yee Ting; Tham M Yao; Tsuyoshi Homma; Danielle Brooks; Isis Katayama Rangel; Gail K Adler; Jose R Romero; Jonathan S Williams; Luminita H Pojoga; Gordon H Williams
Journal:  J Endocrinol       Date:  2019-02-01       Impact factor: 4.286

5.  Resistant hypertension: incidence, prevalence, and prognosis.

Authors:  Eduardo Pimenta; David A Calhoun
Journal:  Circulation       Date:  2012-02-29       Impact factor: 29.690

Review 6.  Drug therapy of apparent treatment-resistant hypertension: focus on mineralocorticoid receptor antagonists.

Authors:  Daniel Glicklich; William H Frishman
Journal:  Drugs       Date:  2015-04       Impact factor: 9.546

7.  Rapid reversal of left ventricular hypertrophy and intracardiac volume overload in patients with resistant hypertension and hyperaldosteronism: a prospective clinical study.

Authors:  Krishna Gaddam; Cecilia Corros; Eduardo Pimenta; Mustafa Ahmed; Thomas Denney; Inmaculada Aban; Seidu Inusah; Himanshu Gupta; Steven G Lloyd; Suzanne Oparil; Ahsan Husain; Louis J Dell'Italia; David A Calhoun
Journal:  Hypertension       Date:  2010-03-29       Impact factor: 10.190

Review 8.  Resistant hypertension and hyperaldosteronism.

Authors:  Carolina C Gonzaga; David A Calhoun
Journal:  Curr Hypertens Rep       Date:  2008-12       Impact factor: 5.369

Review 9.  Interaction of aldosterone and extracellular volume in the pathogenesis of obesity-associated kidney disease: a narrative review.

Authors:  Andrew S Bomback; Philip J Klemmer
Journal:  Am J Nephrol       Date:  2009-03-20       Impact factor: 3.754

10.  Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: results from a randomized trial.

Authors:  Eduardo Pimenta; Krishna K Gaddam; Suzanne Oparil; Inmaculada Aban; Saima Husain; Louis J Dell'Italia; David A Calhoun
Journal:  Hypertension       Date:  2009-07-20       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.